Inhibrx Biosciences Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Inhibrx Biosciences Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
/ 
Others were interested in
Frequently asked questions
To buy Inhibrx Biosciences Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Inhibrx Biosciences Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Inhibrx Biosciences Inc. is INBX:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Inhibrx Biosciences Inc. has its primary listing on NASDAQ. You can trade Inhibrx Biosciences Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Inhibrx Biosciences Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Inhibrx Biosciences Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Inhibrx Biosciences Inc..